CDI Laboratories is a cutting edge proteomics company looking to possibly relocate part of it's operation to New York State.
CDI main technology is it's HuProt microarray, which contains close to 20K purified recombinant human proteins. This is the largest collection available in the world. This technology lends itself to both research as well as development of therapeutic and diagnostic areas of science. In addition CDI currently has a $12.5 million NIH grant to develop specific antibodies to human transcription factors which it will also commercialize.